Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.08% |
| 2 | Financials | 6.03% |
| 3 | Industrials | 5.01% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Healthcare | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
IBM
IBM
$225B
| $242M | 0.15% |
1,651,541
+1,500,030
| +990% | +$218M |
|
|
AABA
102
DELISTED
Altaba Inc
AABA
| $240M | 0.15% |
3,439,600
-499,586
| -13% | -$34.8M |
|
103
JPMorgan Chase
JPM
$962B
| $240M | 0.15% |
2,245,888
+1,993,049
| +788% | +$202M |
|
104
Automatic Data Processing
ADP
$108B
| $240M | 0.15% |
2,046,570
+1,565,940
| +326% | +$179M |
|
|
ALXN
105
DELISTED
Alexion Pharmaceuticals
ALXN
| $238M | 0.14% |
1,986,216
+1,254,689
| +172% | +$153M |
|
106
CALL
Netflix
NFLX
$311B
| $236M | 0.14% |
12,292,000
-2,345,000
| -16% | -$45.2M |
|
107
PUT
Intuitive Surgical
ISRG
$142B
| $236M | 0.14% |
1,938,300
-177,600
| -8% | -$22.2M |
|
108
Walt Disney
DIS
$179B
| $233M | 0.14% |
+2,167,041
| New | +$223M |
|
109
CALL
Microsoft
MSFT
$3.74T
| $231M | 0.14% |
2,698,200
-1,471,700
| -35% | -$121M |
|
|
LLL
110
DELISTED
L3 Technologies, Inc.
LLL
| $230M | 0.14% |
1,163,742
+107,122
| +10% | +$20.4M |
|
111
XPO
XPO
$23.8B
| $228M | 0.14% |
7,203,307
+2,031,956
| +39% | +$52M |
|
112
CVS Health
CVS
$120B
| $227M | 0.14% |
3,130,062
+2,794,481
| +833% | +$203M |
|
113
PUT
Costco
COST
$419B
| $226M | 0.14% |
1,213,000
-58,700
| -5% | -$10.1M |
|
114
lululemon athletica
LULU
$14.3B
| $225M | 0.14% |
2,856,700
+50,631
| +2% | +$3.38M |
|
|
MON
115
DELISTED
Monsanto Co
MON
| $223M | 0.14% |
1,907,902
+994,392
| +109% | +$118M |
|
116
Berkshire Hathaway Class B
BRK.B
$1.11T
| $221M | 0.13% |
1,112,752
+991,564
| +818% | +$188M |
|
117
Mondelez International
MDLZ
$78.9B
| $220M | 0.13% |
5,151,287
+865,006
| +20% | +$36.3M |
|
118
Emerson Electric
EMR
$91.7B
| $220M | 0.13% |
3,149,949
+3,052,545
| +3,134% | +$198M |
|
119
PepsiCo
PEP
$189B
| $219M | 0.13% |
1,823,168
+1,732,425
| +1,909% | +$198M |
|
120
CALL
Chipotle Mexican Grill
CMG
$40.5B
| $217M | 0.13% |
37,480,000
+3,820,000
| +11% | +$22.8M |
|
121
Middleby
MIDD
$5.43B
| $214M | 0.13% |
1,588,485
+906,045
| +133% | +$111M |
|
122
Wells Fargo
WFC
$264B
| $213M | 0.13% |
3,513,670
+3,073,191
| +698% | +$174M |
|
123
CALL
Broadcom
AVGO
$1.98T
| $210M | 0.13% |
8,192,000
-377,000
| -4% | -$9.8M |
|
124
Burlington
BURL
$22.6B
| $210M | 0.13% |
1,703,271
+127,961
| +8% | +$13M |
|
125
Bunge Global
BG
$21.4B
| $209M | 0.13% |
3,120,660
+1,545,446
| +98% | +$105M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.